187 related articles for article (PubMed ID: 9801444)
1. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
Johansen P; Corradin G; Merkle HP; Gander B
J Control Release; 1998 Dec; 56(1-3):209-17. PubMed ID: 9801444
[TBL] [Abstract][Full Text] [Related]
2. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.
Johansen P; Men Y; Audran R; Corradin G; Merkle HP; Gander B
Pharm Res; 1998 Jul; 15(7):1103-10. PubMed ID: 9688067
[TBL] [Abstract][Full Text] [Related]
3. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
4. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
[TBL] [Abstract][Full Text] [Related]
5. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs.
Johansen P; Tamber H; Merkle HP; Gander B
Eur J Pharm Biopharm; 1999 May; 47(3):193-201. PubMed ID: 10382103
[TBL] [Abstract][Full Text] [Related]
6. Improved immunogenicity of a core-coated tetanus toxoid delivery system.
Tobío M; Schwendeman SP; Guo Y; McIver J; Langer R; Alonso MJ
Vaccine; 1999 Nov; 18(7-8):618-22. PubMed ID: 10547420
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
[TBL] [Abstract][Full Text] [Related]
8. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
Hafner AM; Corthésy B; Textor M; Merkle HP
Int J Pharm; 2016 Nov; 514(1):176-188. PubMed ID: 27863662
[TBL] [Abstract][Full Text] [Related]
9. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.
Igartua M; Hernández RM; Esquisabel A; Gascón AR; Calvo MB; Pedraz JL
J Control Release; 1998 Dec; 56(1-3):63-73. PubMed ID: 9801430
[TBL] [Abstract][Full Text] [Related]
12. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
Crotts G; Park TG
J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
[TBL] [Abstract][Full Text] [Related]
14. Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin.
Ertl B; Platzer P; Wirth M; Gabor F
J Control Release; 1999 Sep; 61(3):305-17. PubMed ID: 10477803
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
Yoo HS; Oh JE; Lee KH; Park TG
Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of tetanus toxoid encapsulated in PLGA microspheres.
Jiang W; Schwendeman SP
Mol Pharm; 2008; 5(5):808-17. PubMed ID: 18710256
[TBL] [Abstract][Full Text] [Related]
17. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization.
Chen W; Lu DR
J Microencapsul; 1999; 16(5):551-63. PubMed ID: 10499836
[TBL] [Abstract][Full Text] [Related]
19. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
Jung T; Koneberg R; Hungerer KD; Kissel T
Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
[TBL] [Abstract][Full Text] [Related]
20. Active self-healing encapsulation of vaccine antigens in PLGA microspheres.
Desai KG; Schwendeman SP
J Control Release; 2013 Jan; 165(1):62-74. PubMed ID: 23103983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
